Home » Topics » Regulatory

Regulatory
RSS

Baraclude receives FDA approval

March 31, 2005

Colombian approval for Impavido for cutaneous leishmaniasis

March 29, 2005

Abilify receives new approval

March 9, 2005

Clarinex-D 24 Hour receives FDA approval

March 8, 2005

Controlled release formulations for antiinfective therapy claimed

March 4, 2005

Advitech and the CHULRC to test XP-828L for inflammatory bowel diseases

March 1, 2005

New indications for procarbazine hydrochloride in Japan

March 1, 2005

Cizolirtine enters phase II for stress urinary incontinence

Feb. 25, 2005

Henry Ford Hospital studies Viagra for stroke recovery

Feb. 23, 2005

Amitriptyline studied for painful bladder syndrome and interstitial cystitis

Feb. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...